Intranasal COVID-19 Vaccine Disappointing in First-in-Human Trial

The first-in-human study of intranasal COVID-19 vaccination with an adenovirus-vector vaccine did not induce a consistent mucosal antibody response or a strong systemic response.

Read the full article here

Related Articles